Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Oldham

Showing results (501-510 of 567) with videos related to

Pageof 57
Sort By:
ERJ Open Research|August 29, 2017
Outcomes of immunosuppressive therapy in chronic hypersensitivity pneumonitisAyodeji Adegunsoye, Justin M Oldham, Evans R Fernández Pérez, et al.
American Journal of Respiratory and Critical Care Medicine|September 15, 2018
Prognosticating Outcomes in Interstitial Lung Disease by Mediastinal Lymph Node Assessment. An Observational Cohort Study with Independent ValidationAyodeji Adegunsoye, Justin M Oldham, Catherine Bonham, et al.
American Journal of Respiratory and Critical Care Medicine|February 29, 2024
Machine Learning of Plasma Proteomics Classifies Diagnosis of Interstitial Lung DiseaseYong Huang, Shwu-Fan Ma, Justin M Oldham, et al.
Respiratory Research|March 14, 2020
Design and rationale of a multi-center, pragmatic, open-label randomized trial of antimicrobial therapy - the study of clinical efficacy of antimicrobial therapy strategy using pragmatic design in Idiopathic Pulmonary Fibrosis (CleanUP-IPF) clinical trialKevin J Anstrom, Imre Noth, Kevin R Flaherty, et al.
Chest|July 7, 2026
Longitudinal Mediastinal Lymph Node Dynamics Associate with Mortality and Fibrosis Progression in Fibrotic ILDAyodeji Adegunsoye, Justin M Oldham, Katherine A Aracena, et al.
The New England Journal of Medicine|May 19, 2025
Nerandomilast in Patients with Progressive Pulmonary FibrosisToby M Maher, Shervin Assassi, Arata Azuma, et al.
American Journal of Respiratory and Critical Care Medicine|March 10, 2021
Blood Transcriptomics Predicts Progression of Pulmonary Fibrosis and Associated Natural Killer CellsYong Huang, Justin M Oldham, Shwu-Fan Ma, et al.
American Journal of Respiratory and Critical Care Medicine|April 10, 2025
Proteomic Biomarkers of Survival in Non-IPF Interstitial Lung DiseaseShehabaldin Alqalyoobi, Jennifer A Smith, Manoj V Maddali, et al.
Circulation Research|February 14, 2018
Network Analysis to Risk Stratify Patients With Exercise IntoleranceWilliam M Oldham, Rudolf K F Oliveira, Rui-Sheng Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 29, 2018
[<sup>18</sup>F]Fluorocholine and [<sup>18</sup>F]Fluoroacetate PET as Imaging Biomarkers to Assess Phosphatidylcholine and Mitochondrial Metabolism in Preclinical Models of TSC and LAMEline E Verwer, Taylor R Kavanagh, William J Mischler, et al.
Pageof 57

Showing results (501-510 of 567) with videos related to

Sort By:
Pageof 57
ERJ Open Research|August 29, 2017
Outcomes of immunosuppressive therapy in chronic hypersensitivity pneumonitisAyodeji Adegunsoye, Justin M Oldham, Evans R Fernández Pérez, et al.
American Journal of Respiratory and Critical Care Medicine|September 15, 2018
Prognosticating Outcomes in Interstitial Lung Disease by Mediastinal Lymph Node Assessment. An Observational Cohort Study with Independent ValidationAyodeji Adegunsoye, Justin M Oldham, Catherine Bonham, et al.
American Journal of Respiratory and Critical Care Medicine|February 29, 2024
Machine Learning of Plasma Proteomics Classifies Diagnosis of Interstitial Lung DiseaseYong Huang, Shwu-Fan Ma, Justin M Oldham, et al.
Respiratory Research|March 14, 2020
Design and rationale of a multi-center, pragmatic, open-label randomized trial of antimicrobial therapy - the study of clinical efficacy of antimicrobial therapy strategy using pragmatic design in Idiopathic Pulmonary Fibrosis (CleanUP-IPF) clinical trialKevin J Anstrom, Imre Noth, Kevin R Flaherty, et al.
Chest|July 7, 2026
Longitudinal Mediastinal Lymph Node Dynamics Associate with Mortality and Fibrosis Progression in Fibrotic ILDAyodeji Adegunsoye, Justin M Oldham, Katherine A Aracena, et al.
The New England Journal of Medicine|May 19, 2025
Nerandomilast in Patients with Progressive Pulmonary FibrosisToby M Maher, Shervin Assassi, Arata Azuma, et al.
American Journal of Respiratory and Critical Care Medicine|March 10, 2021
Blood Transcriptomics Predicts Progression of Pulmonary Fibrosis and Associated Natural Killer CellsYong Huang, Justin M Oldham, Shwu-Fan Ma, et al.
American Journal of Respiratory and Critical Care Medicine|April 10, 2025
Proteomic Biomarkers of Survival in Non-IPF Interstitial Lung DiseaseShehabaldin Alqalyoobi, Jennifer A Smith, Manoj V Maddali, et al.
Circulation Research|February 14, 2018
Network Analysis to Risk Stratify Patients With Exercise IntoleranceWilliam M Oldham, Rudolf K F Oliveira, Rui-Sheng Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 29, 2018
[<sup>18</sup>F]Fluorocholine and [<sup>18</sup>F]Fluoroacetate PET as Imaging Biomarkers to Assess Phosphatidylcholine and Mitochondrial Metabolism in Preclinical Models of TSC and LAMEline E Verwer, Taylor R Kavanagh, William J Mischler, et al.
Pageof 57